Mary Kay Fenton

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Kay Fenton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Chief Financial Officer Common Stock 126,380 $1,721,295 $13.62 20 Feb 2026 Direct
Talaris Therapeutics, Inc. Chief Financial Officer Common Stock 68,054 $1,156,237 $16.99 03 Jul 2023 Direct
Cullinan Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 137,500 18 Feb 2026 Direct
Oncorus, Inc. Director Stock Option (right to buy) 12,500 23 Jun 2022 Direct

Insider Reports Filed by Mary Kay Fenton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Therapeutics, Inc. 20 Feb 2026 1 -$59,901 4 Chief Financial Officer 23 Feb 2026, 17:00
CGEM Cullinan Therapeutics, Inc. 18 Feb 2026 2 $0 4 Chief Financial Officer 19 Feb 2026, 17:00
CGEM Cullinan Therapeutics, Inc. 31 Dec 2025 1 +$175 4 Chief Financial Officer 05 Jan 2026, 17:01
CGEM Cullinan Therapeutics, Inc. 19 Feb 2025 2 $0 4 Chief Financial Officer 21 Feb 2025, 18:00
CGEM Cullinan Therapeutics, Inc. 29 Apr 2024 1 $0 4 Chief Financial Officer 30 Apr 2024, 21:02
CGEM Cullinan Therapeutics, Inc. 29 Apr 2024 0 $0 3 Chief Financial Officer 30 Apr 2024, 20:58
TRML Talaris Therapeutics, Inc. 03 Jul 2023 1 -$39,874 4 Chief Financial Officer 06 Jul 2023, 17:20
TRML Talaris Therapeutics, Inc. 01 Feb 2023 2 $0 4 Chief Financial Officer 03 Feb 2023, 15:57
TRML Talaris Therapeutics, Inc. 10 Sep 2022 1 $0 4 Chief Financial Officer 13 Sep 2022, 16:29
/report/000120919122039086-fenton-mary-kay-2022-06-23 Oncorus, Inc. 23 Jun 2022 1 $0 4 Director 24 Jun 2022, 06:44
TRML Talaris Therapeutics, Inc. 01 Feb 2022 2 +$13,000 4 Chief Financial Officer 02 Feb 2022, 17:00
/report/000120919121041617-fenton-mary-kay-2021-06-16 Oncorus, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 17:57